Fate Therapeutics, Inc. Competitors

FATE 
$4.76
*  
0.03
0.63%
Get FATE Alerts
*Delayed - data as of May 4, 2015 11:35 ET  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale ▼ NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Biogen Inc.
BIIB: NASDAQ-GS
$ 387.03 0.81 ▲ 611,716 $ 393.8925
$ 387.01
$ 480.18
$ 278.10
27.92 90,802,656,420
Amgen Inc.
AMGN: NASDAQ-GS
$ 162.39 2.03 ▲ 1,223,625 $ 163.96
$ 161.45
$ 173.60
$ 109.41
21.91 123,231,437,790
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 133.76 -5.18 ▼ 671,142 $ 137.995
$ 128.22
$ 141.48
$ 17.40
NE 4,356,028,160
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 106.144 1.13 ▲ 5,387,523 $ 107.50
$ 105.22
$ 116.83
$ 76.6301
12.05 158,091,085,888
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 99.88 0.99 ▲ 134,146 $ 103.27
$ 98.75
$ 122.88
$ 60.19
NE 3,691,365,040
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 97.56 -0.64 ▼ 14,237 $ 99.25
$ 97.56
$ 102.80
$ 33.49
35.74 2,405,536,920
Bio-Techne Corp
TECH: NASDAQ-GS
$ 96.35 -0.38 ▼ 52,957 $ 98.12
$ 96.25
$ 103
$ 85.96
31.08 3,577,860,900
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 53.32 1.91 ▲ 421,432 $ 55.28
$ 51.51
$ 89.21
$ 21
NE 2,267,219,720
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 53.09 -5.43 ▼ 1,263,561 $ 53.09
$ 47.01
$ 79.50
$ 40.16
NE 1,303,040,960
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 45.89 1.07 ▲ 980,667 $ 47.03
$ 44.63
$ 66
$ 34.71
NE 4,149,649,140
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 40 -0.45 ▼ 85,128 $ 41.18
$ 39.61
$ 64.35
$ 9.66
NE 974,400,000
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 36.43 0.92 ▲ 677,239 $ 37.11
$ 35.26
$ 45.36
$ 12.6325
NE 3,104,054,580
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 34.11 0.08 ▲ 551,269 $ 35.26
$ 33.965
$ 44.95
$ 30.05
NE 4,240,521,090
Cellectis S.A.
CLLS: NASDAQ-GM
$ 32.9696 0.06 ▲ 18,520 $ 33.02
$ 32.9201
$ 42.04
$ 30.40
NE 1,086,974,742
Repligen Corporation
RGEN: NASDAQ-GS
$ 31.27 -0.22 ▼ 121,063 $ 32.129
$ 30.76
$ 35.47
$ 15.4926
125.08 1,023,216,940
Avalanche Biotechnologies, Inc.
AAVL: NASDAQ-GM
$ 31.06 -2.11 ▼ 295,758 $ 32.13
$ 29.47
$ 62.48
$ 22
NE 780,320,380
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 31.03 1.26 ▲ 308,513 $ 31.35
$ 30.01
$ 45.45
$ 28.26
94.03 1,321,102,250
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 29.17 0.43 ▲ 64,617 $ 30.38
$ 28.96
$ 48.50
$ 23.61
NE 940,820,010
Heska Corporation
HSKA: NASDAQ-CM
$ 28.82 0.14 ▲ 19,961 $ 30.41
$ 28.39
$ 31.87
$ 10.38
72.05 182,142,400
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 27.23 1.97 ▲ 39,804 $ 27.29
$ 26.60
$ 28.50
$ 20.2601
NE 1,004,514,700
Qiagen N.V.
QGEN: NASDAQ-GS
$ 24.27 0.21 ▲ 235,060 $ 24.44
$ 24.20
$ 25.91
$ 20.73
49.53 5,663,525,850
Cellular Biomedicine Group, Inc.
CBMG: NASDAQ-GM
$ 23.77 -0.19 ▼ 9,626 $ 24.98
$ 23.6001
$ 49
$ 9
NE 261,351,150
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 22.94 -0.68 ▼ 35,155 $ 24.162
$ 22.87
$ 33.30
$ 12.27
NE 762,938,520
TrovaGene, Inc.
TROVU: NASDAQ-CM
$ 20.72 unch n/a
n/a
$ 21.30
$ 8.02
NE 23,828,000
La Jolla Pharmaceutical Company
LJPC: NASDAQ-CM
$ 19.6268 0.39 ▲ 23,311 $ 20.091
$ 19.25
$ 24.89
$ 6.17
NE 298,837,657